Literature DB >> 7596443

Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.

T Bizebard1, B Gigant, P Rigolet, B Rasmussen, O Diat, P Bösecke, S A Wharton, J J Skehel, M Knossow.   

Abstract

Haemagglutinin (HA) is the influenza surface glycoprotein that interacts with infectivity-neutralizing antibodies. As a consequence of this immune pressure, it is the variable virus component, which is important in antigenic drift, that results in recurrent epidemics of influenza. We have determined the crystallographic structure of a complex formed between the antigen-binding fragment (Fab) of a neutralizing antibody and the membrane-distal domain ('HA top') of a HA subunit prepared from HA in its membrane-fusion-active conformation. A dramatic change is seen in the structure of the Fab-combining site on complex formation. Our results indicate that neutralization of infectivity by this antibody involves the inhibition of receptor binding, and demonstrate how influenza virus can maintain its conserved receptor-binding site despite the immune selective pressure for change in this region of the molecule; they also contribute to a complete description of the endosomal pH-induced fusion-active HA structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596443     DOI: 10.1038/376092a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  98 in total

1.  Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus.

Authors:  P D Kwong; R Wyatt; Q J Sattentau; J Sodroski; W A Hendrickson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity.

Authors:  S Villeneuve; H Souchon; M M Riottot; J C Mazie; P Lei; C P Glaudemans; P Kovác; J M Fournier; P M Alzari
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

3.  Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.

Authors:  Jing Qi Feng; Krystyna Mozdzanowska; Walter Gerhard
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 4.  Genetic and structural determinants of virus neutralizing antibodies.

Authors:  J E Crowe; R O Suara; S Brock; N Kallewaard; F House; J H Weitkamp
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid:water interface.

Authors:  Justin L Lorieau; John M Louis; Ad Bax
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

6.  Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.

Authors:  Shaguna Seth; Annelet Vincent; R W Compans
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Structural changes in Influenza virus at low pH characterized by cryo-electron tomography.

Authors:  Juan Fontana; Giovanni Cardone; J Bernard Heymann; Dennis C Winkler; Alasdair C Steven
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

8.  Predicting interaction sites from the energetics of isolated proteins: a new approach to epitope mapping.

Authors:  Guido Scarabelli; Giulia Morra; Giorgio Colombo
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

9.  Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses.

Authors:  Natalie J Thornburg; David P Nannemann; David L Blum; Jessica A Belser; Terrence M Tumpey; Shyam Deshpande; Gloria A Fritz; Gopal Sapparapu; Jens C Krause; Jeong Hyun Lee; Andrew B Ward; David E Lee; Sheng Li; Katie L Winarski; Benjamin W Spiller; Jens Meiler; James E Crowe
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

10.  Structural basis for Marburg virus neutralization by a cross-reactive human antibody.

Authors:  Takao Hashiguchi; Marnie L Fusco; Zachary A Bornholdt; Jeffrey E Lee; Andrew I Flyak; Rei Matsuoka; Daisuke Kohda; Yusuke Yanagi; Michal Hammel; James E Crowe; Erica Ollmann Saphire
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.